What, Where, When, and How to Automate Flow Cytometry

Once a technology that was only applicable to manual handling of individual samples, recent advances in flow cytometry technology have enabled rapid sample throughput. Improvements in cytometer design and reliability have facilitated automation and made flow cytometry an indispensable tool for screening applications.

However, significant efficiency savings have yet to be fully realized. Considerations around instrument choice including API flexibility, as well as the presence of automated fault recovery and maintenance features, are important. But, as the capability and reliability of flow cytometry instrumentation improves, other elements of the workflow, such as lengthy sample preparation times, become limiting. Automation of the entire workflow is a potential solution but may be impractical in a single location and tying every instrument into a single workstation could limit flexibility, especially in a dynamic research environment.

Join Bio-Rad Laboratories and HighRes Biosolutions with Tim Ashlin, Principal Investigator at GSK as together we explore what, where, when, and how to automate flow cytometry. Get exclusive insight into new products that aim to unlock more of the potential of automation in every laboratory and see current and future plans for flow cytometry automation at GSK.